Even the experts took off, as she doses of the study learned about the surprisingly mild reaction to excessive LSD. And with strong we: my enormously strong. Lysergic acid diethylamide-25 in April 1943 by the Swiss chemist Albert Hofmann in his laboratory at Sandoz in Basel discovered, is considered to be one of the most effective substances at all. 200 micro-grams of lead intoxication, to change the feeling of the body, affect the See and Hear. When asked, Albert Hofmann, after the most beautiful experience, which he had made under the influence of LSD, he said: "to be the realization of part of the living creation." No wonder he was of the view that a chemist would have to be mystics.
Now, the canadian addiction expert, Mark Halden and his colleague, Brigitta Woods three cases of massive, involuntary LSD-Overdose investigated. A 46-Year-old woman sniffed the 550-fold dose of the normal Trips; they had thought it was cocaine. Two other women also took a massive Overdose. Heaps and Woods published their case studies in the journal "Journal of Studies on Alcohol and Drugs".
By chance, he discovered lysergic acid diethylamide Albert Hofmann in an undated footage, which shows him in the lab. Photo: Novartis
their findings sound incredible: first, none of the three women suffered negative after-effects in spite of the massive Overdose, you developed so no psychotic or physical symptoms. Secondly, they were of course anxious moments, no wonder, under such circumstances, but also peaceful, and happy. The woman with the 550-times the dose is not remembered the first twelve hours, often had to vomit, but felt the next 24 hours is good to relax. Thirdly and most importantly, two of the three involuntary test subject had suffered inside of years of infirmity. The a plagued a long-standing ankle disease, the had to treat it with strong morphine. The other was a manic depressive, so bipolar.
The industry has little interest
In a number of countries, research on the therapeutic effects of Hallucinogens, with Switzerland belongs to the avant-garde. The Solothurn psychiatrist Peter Gasser (read here the Interview with him) put LSD in cancer patients, and his Zurich colleague, Franz Xaver Vollenweider (we also talked) will examine the treatment of Psilocybin in depression and alcoholism strictly scientific.
studies with psychedelics, for safety reasons, expensive, and financing remains difficult, because the pharmaceutical industry shows no interest. Because where there is no Patent, can be earning nothing. The three cases of extreme Overdoses, give a hint to the fact that LSD itself is not in high doses is fatal. Unlike tobacco, alcohol, and opiates. The are all legally available. Without any therapeutic value.
Created: 03.03.2020, 17:03 PMUpdated Date: 04 March 2020, 09:03